BIO NOTEBOOK: Roche's Genentech sees hope in Alzheimer's research
This article was originally published in Scrip
Executive Summary
A lot of companies continue studying Alzheimer’s and, though their numbers are not growing, the quality of their research is improving. That’s the assessment from Alexander Schuth, head of neuroscience partnering and business development for Genentech.